Eurofins Announces Acquisition of Assets of Gomti Life Sciences

▴ Eurofins
Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life Sciences Private Limited through a Business Transfer Agreement.

Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life Sciences Private Limited through a Business Transfer Agreement. The assets include a fully equipped state-of-the-art manufacturing facility located in Bidadi Industrial Area, Bangalore, India, with cGMP pilot plant, intermediate area and ISO class 8 clean rooms and a total reactor capacity of about 45 KL.

With this acquisition, Eurofins Advinus will be able to manufacture RSMs, intermediates, APIs and NCEs. The company can now support drug substance requirements from multi kilogram to MT scale for Toxicology studies, clinical trials and launch quantities.

Rajiv Malik, MD of Eurofins Advinus Limited commented: This acquisition could be a game changer for Eurofins Advinus as it enables the group to enter clinical development and commercial supply part of the Pharma R&D value chain through cGMP API supplies of NCEs. This addition is also a part of a larger foray of the Eurofins group into CDMO / CRAMS market.

Tags : #Eurofins #Gomtilife #Sciences #Clinical #Development #Commercialsupply #Medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

NHPC organizes blood donation camp to support blood banks July 14, 2020
Studies predicts surge in HIV, TB, and Malaria deaths due to COVID-19July 14, 2020
AIIMS Patna starts human trial of Coronavirus vaccineJuly 14, 2020
World’s population likely to shrink after mid-century : LancetJuly 14, 2020
21 deaths, 1,654 fresh Covid-19 cases in UP; total count 38,130July 14, 2020
Over 90 doctors have died so far IMAJuly 14, 2020
Glenmark cuts price of Covid-19 drug Favipiravir version to $1 per tabJuly 14, 2020
19 States, UTs report higher recovery rate than national average of 63%July 14, 2020
Govt advises cautious use of Remdesivir, Tocilizumab for Covid-19 July 13, 2020
Govt in process of selecting 3 bulk drug and 4 medical devices parkJuly 13, 2020
Glenmark commences 1000 patients surveillance study ; FabiFluJuly 13, 2020
Neuherbs enters in sanitation category, launches sub-brand NeusafeJuly 13, 2020
Thailand gears up for human trials for their COVID-19 vaccineJuly 13, 2020
How the world's busiest airport envisions travel amid COVID-19July 13, 2020
Mexico coronavirus death count risesJuly 13, 2020
Florida sets 1-day record of new COVID-19 casesJuly 13, 2020
Russian University claims successful trials of 1st COVID-19 vaccineJuly 13, 2020
Over 5,53000 recovered so far: COVID recovery rate reaches 63.01%July 13, 2020
Bihar reports largest ever spike with 1266 COVID cases in last 24 hrsJuly 13, 2020
Latur declares 14 days lockdown starting from July 15July 13, 2020